Legend Biotech (LEGN) Change in Cash (2019 - 2025)
Legend Biotech (LEGN) posted Change in Cash of $623.0 million for Q4 2025, up 3332.89% on a QoQ basis from $18.1 million in Q3 2025, and up 460.95% year-over-year from $111.1 million in Q4 2024.
Legend Biotech (LEGN) Change in Cash (2019 - 2025) Analysis & Trends
Legend Biotech's Change in Cash history runs 7 years deep, the most recent figure standing at $623.0 million for Q4 2025.
- Quarterly Change in Cash rose 460.95% year-over-year to $623.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $615.1 million (up 162.07% YoY) and the FY2025 annual result came in at $615.2 million, up 162.08% from the prior year.
- Change in Cash was $623.0 million for Q4 2025 at Legend Biotech, up from $18.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $623.0 million in Q4 2025 and bottomed at -$696.3 million in Q2 2024.
- A 5-year average of $22.4 million and a median of -$11.4 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash sank 611.55% — and 2023, when it surged 19899.89%.
- Legend Biotech's Change in Cash stood at $350.5 million in 2021, then sank by 107.3% to -$25.6 million in 2022, then soared by 1322.17% to $312.8 million in 2023, then plunged by 155.18% to -$172.6 million in 2024, then surged by 460.95% to $623.0 million in 2025.
- Business Quant data shows LEGN's Change in Cash at $623.0 million in Q4 2025, $18.1 million in Q3 2025, and -$179.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 623.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 623.00 Mn |
| Sep 30, 2025 | 18.15 Mn |
| Jun 30, 2025 | -179.56 Mn |
| Mar 31, 2025 | 153.55 Mn |
| Dec 31, 2024 | -172.60 Mn |
| Sep 30, 2024 | 257.69 Mn |
| Jun 30, 2024 | -696.33 Mn |
| Mar 31, 2024 | -379.80 Mn |
| Dec 31, 2023 | 312.79 Mn |
| Sep 30, 2023 | -268.96 Mn |
| Jun 30, 2023 | 570.80 Mn |
| Mar 31, 2023 | -123.63 Mn |
| Dec 31, 2022 | -25.59 Mn |
| Sep 30, 2022 | 433.50 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | -311.16 Mn |
| Dec 31, 2021 | 350.53 Mn |
| Sep 30, 2021 | -149.12 Mn |
| Jun 30, 2021 | 75.54 Mn |
| Mar 31, 2021 | -43.73 Mn |